OMDA Form 144: 637‑Share Sale Planned After Option Exercise

OMDA (Form 144) reports planned and recent Rule 144 sales of Common stock by a reporting holder.

Rhea-AI Filing Summary

OMDA (Form 144) reports planned and recent Rule 144 sales of Common stock by a reporting holder. The filing lists a proposed sale of 637 shares tied to an exercise of stock options to occur on 07/01/2026 for cash. The filing also lists multiple 10b5-1 sales executed in June 2026, including 6,894 shares on 06/12/2026 for $120,123.06 and several smaller trades between 06/22/2026 and 06/30/2026.

Insights

Corporate Governance Analyst

Routine Rule 144 notices and 10b5-1 executions; primarily administrative disclosure.

The filing documents a planned 07/01/2026 sale of 637 shares following an exercise of stock options, with settlement in cash. It also itemizes multiple 10b5-1 sales in June 2026, the largest shown: 6,894 shares for $120,123.06 on 06/12/2026.

These entries are procedural disclosures of sales by an insider or affiliate. Cashflow treatment is described as Cash for the planned sale; further context on beneficial ownership or motivation is not provided in the excerpt.

Key Figures

Planned sale: 637 shares June 12, 2026 sale: 6,894 shares June 29, 2026 sale: 2,083 shares +2 more

5 metrics

Planned sale 637 shares sale tied to exercise of stock options on 07/01/2026

June 12, 2026 sale 6,894 shares 10b5-1 sale on 06/12/2026 for $120,123.06

June 29, 2026 sale 2,083 shares 10b5-1 sale on 06/29/2026 for $43,743.00

June 26, 2026 sale 2,084 shares 10b5-1 sale on 06/26/2026 for $41,680.00

June 30, 2026 sale 405 shares 10b5-1 sale on 06/30/2026 for $8,910.00

Key Terms

10b5-1 sales, Exercise of Stock Options, Rule 144

3 terms

10b5-1 sales regulatory

"10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Exercise of Stock Options financial

"Common | 07/01/2026 | Exercise of Stock Options"

Rule 144 regulatory

"Form 144 filing metadata and securities to be sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does OMDA's Form 144 disclose about planned stock sales?

It discloses a planned sale of 637 shares tied to an exercise of stock options scheduled for 07/01/2026, to be settled for cash. The filing labels the transaction method as an exercise and sale under Rule 144.

Which executed 10b5-1 sales are listed in the excerpt for OMDA?

The excerpt lists multiple 10b5-1 sales in June 2026, including 6,894 shares on 06/12/2026 for $120,123.06, and additional trades on 06/22, 06/24, 06/26, 06/29, and 06/30/2026 with varying shares and proceeds.

Who is the reporting seller named in the filing excerpt?

The excerpt identifies transactions described as 10b5-1 Sales for CRAIG GRACEY with an address at 611 Gateway Blvd, Suite 120, South San Francisco, CA 94080, shown for multiple June 2026 sales.

How is the planned 07/01/2026 sale to be settled according to the filing?

The planned 07/01/2026 sale of 637 shares is shown as resulting from an exercise of stock options and indicated to be settled for cash in the filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002021724
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	OMADA HEALTH INC
SEC File Number	001-42679
Address of Issuer	611 Gateway Blvd, Suite 120 South San Francisco CALIFORNIA 94080
Phone	8889878337
Name of Person for Whose Account the Securities are To Be Sold	CRAIG GRACEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	637	13982.15	59448507	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2026	Exercise of Stock Options	Issuer			637	07/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/30/2026	405	8910.00
10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/29/2026	2083	43743.00
10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/26/2026	2084	41680.00
10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/24/2026	2083	39601.58
10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/22/2026	2083	37494.00
10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/12/2026	6894	120123.06

144: Remarks and Signature

Remarks
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Craig Phillip Gracey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)